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Mitochondrial DNA deletions and depletion within paraspinal muscles
Aims: Although mitochondrial abnormalities have been
reported within paraspinal muscles in patients with axial
weakness and neuromuscular disease as well as with
ageing, the basis of respiratory deficiency in paraspinal
muscles is not known. This study aimed to determine the
extent and basis of respiratory deficiency in paraspinal
muscles from cases undergoing surgery for degenerative
spinal disease and post mortem cases without a history
of spinal disease, where age-related histopathological
changes were previously reported. Methods: Cervical and
lumbar paraspinal muscles were obtained peri-operatively
from 13 patients and from six post mortem control cases
(age range 18–82 years) without a neurological disease.
Sequential COX/SDH (mitochondrial respiratory chain
complex IV/complex II) histochemistry was performed to
identify respiratory-deficient muscle fibres (lacking
complex IV with intact complex II activity). Real-time
polymerase chain reaction, long-range polymerase
chain reaction and sequencing were used to identify
and characterize mitochondrial DNA (mtDNA) deletions
and determine mtDNA copy number status. Mito-
chondrial respiratory chain complex subunits were
detected by immunohistochemistry. Results: The density
of respiratory-deficient fibres increased with age. On
average, 3.96% of fibres in paraspinal muscles were
respiratory-deficient (range 0–10.26). Respiratory defi-
ciency in 36.8% of paraspinal muscle fibres was due to
clonally expanded mtDNA deletions. MtDNA depletion
accounted for further 13.5% of respiratory deficiency.
The profile of immunohistochemically detected sub-
units of complexes was similar in respiratory-deficient
fibres with and without mtDNA deletions or mtDNA
depletion. Conclusions: Paraspinal muscles appeared to
be particularly susceptible to age-related mitochondrial
respiratory chain defects. Clonally expanded mtDNA
deletions and focal mtDNA depletion may contribute
towards the development of age-related postural
abnormalities.
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Introduction
The paraspinal muscles are essential for truncal move-
ment and maintaining the erect posture. Clinical presen-
tation of isolated paraspinal muscle weakness (axial
myopathy) includes dropped head and bent spine syn-
dromes as well as camptocormia [1–5]. Paraspinal muscle
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weakness may also be part of a diffuse process as described
in polymyositis, inclusion body myositis, myasthenia
gravis, amyotrophic lateral sclerosis and primary mito-
chondrial disorders due to mutations in mitochondrial
DNA (mtDNA) [6–8]. Histopathological studies of
paraspinal muscles from axial myopathies and a number
of diffuse muscle disorders identified mitochondrial
abnormalities in a proportion of patients [1,2,4,5,7].
Respiratory-deficient fibres [lacking mitochondrial respi-
ratory chain complex IV or cytochrome c oxidase (COX)
and with intact complex II or succinate dehydrogenase
(SDH) activity, also termed COX-deficient] and mitochon-
drial abnormalities at an ultrastructural level were
reported within paraspinal muscles in patients with
degenerative cervical and lumbar spine and post mortem
controls without a history of degenerative spine disease
[1,9,10]. Wharton et al. reported the histopathological
changes within cervical paraspinal muscles in the surgical
and post mortem cases to be comparable and age-related
[10]. However, the extent and basis of respiratory defi-
ciency within paraspinal muscles in such cases is not
known.
The mitochondrial respiratory chain complexes are
made up of multiple subunits encoded by nuclear DNA
and mtDNA [11]. Given that there are multiple copies of
mtDNA in single cells, the proportion of any mtDNA
mutation – as a percentage of total mtDNA copies (hetero-
plasmy) – needs to exceed a threshold level to cause
respiratory deficiency [11]. High heteroplasmy levels of
inherited and sporadic mtDNA deletions are well recog-
nized within respiratory-deficient limb skeletal muscle
fibres in certain primary mitochondrial disorders [11,12].
Somatic mtDNA deletions are also recognized with ageing
in limb skeletal muscles [13–15]. Irrespective of the mode
of mtDNA deletion generation, high levels of mtDNA dele-
tion and mtDNA depletion frequently affect the activity as
well as subunits of mtDNA encoded complexes (complex I,
complex III, complex IV and complex V) [11]. Complex II,
which is encoded entirely by nuclear DNA, is spared in
conditions due to or associated with mtDNA mutations
(deletions or point mutations) and mtDNA depletion.
MtDNA mutations and copy number abnormalities may
be investigated at a single cell level using several well-
established molecular biology techniques. A proportion of
cases with histochemical evidence of mitochondrial dys-
function in limb skeletal muscle and supposed primary
mitochondrial disease, however, remained unexplained
[16]. In cases where a mitochondrial genetic abnormality
of the respiratory chain is not apparent, the profile of
mitochondrial respiratory chain subunits detected by
immunohistochemistry may guide towards a possible
nuclear genetic defect [16,17].
The aim of this study was to determine the density and
the basis of respiratory-deficient fibres in paraspinal
muscles from patients undergoing spinal surgery as well
as autopsy cases without a history of degenerative spine
or neuromuscular disease. We used histochemical, immu-
nohistochemical and molecular biology techniques to
study paraspinal muscles from 19 cases (age range 18–
82 years). The density of respiratory-deficient fibres in
paraspinal muscles increased with age and was greater
than previously reported within limb skeletal muscles in
controls [13–15]. Approximately a third of respiratory-
deficient fibres harboured clonally expanded mtDNA dele-
tions while total mtDNA copy number was depleted in
approximately a tenth of all respiratory-deficient fibres.
Immunohistochemical profile of respiratory chain sub-
units in respiratory-deficient fibres with and without
mtDNA deletions or mtDNA depletion was similar.
Paraspinal muscles appear to be particularly susceptible to
mitochondrial respiratory chain defects and somatic
mtDNA deletions, which may contribute towards the age-
related postural abnormalities.
Materials and methods
Patients and tissue processing
Nineteen patients were used in this study (Table 1) with
a median age of 62 years (range 18–82 years). Either
deep cervical (semispinalis cervicis) or lumbar paraspinal
muscles (multifidus) were sampled peri-operatively and
deep lumbar deep paraspinal muscles were obtained from
the post mortem cases. Post mortem paraspinal muscle
samples from cases without degenerative spine disease or
neuromuscular disorders were obtained from UK Multiple
Sclerosis and Parkinson’s Tissue Bank. None of the
patients had a neurodegenerative disorder including Par-
kinson’s disease or multiple sclerosis or a family history
indicative of a neuromuscular, primary mitochondrial dis-
order. Physical signs suggestive of a primary mitochon-
drial disorder were absent in all cases. All patients were
mobile with muscle strength of at least grade 4 (Medical
Research Council Scale) and none had spine immobilized
prior to surgery. Newcastle and North Tyneside 1
Research Ethics Committee (09/H/0906/675) approved
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this study. Samples were snap frozen in liquid isopentane
at -150°C and stored at -80°C. Tissue blocks were orien-
tated transversely and serially sectioned on a cryostat onto
both glass and PEN membrane slides (Leica, Bannock-
burn, IL, USA) at a thickness of 15 mm.
Histochemistry
Cryosections were subjected to haematoxylin and eosin
(H&E) staining, ATPase (pH 4.3) staining and sequential
COX/SDH histochemistry. For ATPase (pH 4.3) his-
tochemistry, sections were incubated in a 0.2 M acetate
solution (pH 4.3) for 30 min and washed in water fol-
lowed by incubation in an ATPase medium (pH 9.5) for
45 min at 37°C. Sections were washed in solutions of 1%
calcium chloride, 2% cobalt nitrate and incubated in a 1%
solution of ammonium sulphide for 2 min. Sections were
then mounted in Canada Balsam. COX/SDH was per-
formed as previously described [18]. For the purposes of
mtDNA copy number analysis, membrane slide sections
were incubated in SDH media and serial sections were
used to identify respiratory-deficient muscle fibres [19].
Immunohistochemistry
Immunohistochemistry was performed on serial glass sec-
tions to ascertain status of mitochondrial respiratory
chain complex subunits and histological characterization.
Cryosections were air dried for 1 h before being fixed
in a cold solution of 4% paraformaldehyde for 10 min
and subjected to immunohistochemistry as previously
described [20]. The primary antibodies were applied over-
night at 4°C (Table S1). Sections were washed in Tris-
buffered saline and developed using the Menapath X-Cell
Plus HRP Polymer Detection System (A. Menarini Diag-
nostics Ltd, Wokingham, UK) as per manufacturer’s
guidelines.
Laser microdissection and long-range
polymerase chain reaction
Individual COX-deficient muscle fibres and groups of
COX-positive muscle fibres were laser microdissected
(Leica) for long-range polymerase chain reaction
(PCR) analysis. Fibres were lysed and long-range PCR
was used to identify mtDNA deletions within the major
arc of the mitochondrial genome using the Expand Long
Template PCR System (Roche, Indianapolis, IN, USA), as
previously described [20]. DNA products were separated
using a 0.7% agarose gel containing ethidium bromide
and viewed under UV light. Blood DNA from an age-
matched individual without any medical diagnoses was
used as wild-type control.
Table 1. Clinical details
Patient Age (gender) Surgical procedure Muscle sampled Duration of symptoms
1 18 (F) Scoliosis surgery Lumbar NA
2 18 (F) Scoliosis surgery Lumbar NA
3 42 (F) L5/S1 decompression Lumbar 1.5 years
4 42 (M) C6/C7 decompression Cervical 9 months
5 51 (F) C4/C5 decompression Cervical 4 years
6 51 (M) C5/C7 fusion Cervical 9/12
7 52 (F) C1 decompression Cervical NA
8 53 (M) L3/L4 decompression Lumbar NA
9* 57 (F) – Lumbar –
10* 62 (F) – Lumbar –
11* 64 (M) – Lumbar –
12 64 (M) L3/L4 decompression Lumbar 4.5 years
13 65 (M) L4/L5 decompression Lumbar 1.2 years
14* 71 (M) – Lumbar –
15 72 (M) C3/C4 foraminectomy Cervical 6 months
16 74 (M) L4/L5 decompression Lumbar 3 years
17* 77 (M) – Lumbar –
18 80 (M) Occipitocervical fusion Cervical 2 months
19* 82 (M) – Lumbar –
The asterisk (*) denotes post mortem cases. The mean age of surgical cases was not statistically difference compared with the mean age of post
mortem cases (P = 0.069). The control cases (post mortem and surgical) did not have clinical or pathological evidence of a central nervous system
disorder. NA, not available.
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Real-time PCR
Membrane slides with SDH histochemistry alone were
used to laser microdissect COX-positive and COX-deficient
fibres for real-time PCR analysis. Images of COX/SDH
staining were taken from serial sections and used as a
reference to identify COX-positive and COX-deficient fibres.
The area of the dissected fibre (mm2) was noted for the
purposes of copy number analysis using the laser micro-
dissection software (Leica). Real-time PCR was used to
determine both levels of mtDNA deletions and mtDNA
copy number (of total and wild type). A real-time PCR
assay, which determines the simultaneous and equally
efficient amplification of the MTND1 and MTND4
regions, was used to investigate levels of mtDNA deletions,
as previously described [20,21]. Briefly, 2 ml of DNA
from a single muscle fibre was added to a mastermix of
Taqman® universal PCR mastermix (Applied Biosystems,
Life Technologies, Carlsbad, CA, USA), 100 nM probes for
a region in MTND1 (5′-CCATCACCCTCTACATCACCGC
CC-3′) and MTND4 (5′-CCGACATCATTACCGGGTTTTCC
TCTTG-3′), 300 nM forward and reverse primers to
amplify a region in both MTND1 (forward: 5′-CCCTAA
AACCCGCCACATCT-3′; reverse: 5′-GAGCGATGGTGAGA
GCTAAGGT-3′) and MTND4 (forward: 5′-CCATTCTCCT
CCTATCCCTCAAC-3′; reverse: 5′-CACAATCTGATGT
TTTGGTTAAACTATATTT-3′) and dH2O. Cycle conditions
consisted of a cycle of 2 min at 50°C and 10 min at 95°C
followed by 40 cycles of 15 s at 95°C and 1 min at 60°C.
Determining mtDNA heteroplasmy level and
mtDNA copy number
MtDNA deletion levels were calculated using a multiplex
real-time PCR assay and the DCt method, based on the
observation that a region in MTND4, located in the major
arc, is deleted in 96% of cases with multiple mtDNA dele-
tions, while a region in MTND1, in the minor arc of the
mitochondrial genome, is rarely deleted [21]. The change
in cycle threshold or DCt (CtND1–ND4) and the calculated
relative copy number (R = 2-DCt), taking background fluo-
rescence into account, were used to determine the per-
centage level of deleted mtDNA [(1 - R) ¥ 100] [22]. For
all samples, DCt values were obtained in triplicate and
were used to calculate mtDNA deletion levels. Within each
experiment, control samples of known mtDNA deletion
heteroplasmy levels as well as a wild type blood control
were run to quality control the assay.
For determining mtDNA copy number, a standard curve
was generated for both MTND1 and MTND4 using
samples with known copy number values. A standard
curve was used with all samples from lysed muscle fibres
tested. Total mtDNA copy number was determined from
the MTND1 Ct values, using the standard curve, while the
wild-type mtDNA copy number was determined from
the MTND4 Ct values. MtDNA copy number values were
expressed as per mm2 prior to determining the ratio of
mtDNA copies between COX-deficient and COX-positive
fibres for each individual case (mean copy number of 10
random COX-positive fibres) to exclude interindividual
variability [19]. MtDNA depletion in respiratory-deficient
fibres was defined as ratio of mtDNA copies below the
lower limit of 95% confidence interval of mtDNA copy
ratios in COX-positive fibres.
MtDNA sequencing
To confirm the presence of clonally expanded mtDNA
deletions and characterize mtDNA deletion breakpoints,
PCR products were extracted using a Qiagen (Valencia,
CA, USA) gel extraction kit as per manufacturer’s guide-
lines. Cycle sequencing was carried out as previously
described using an ABI 3130xl Genetic Analyser (Applied
Biosystems) [20]. Sequences were subsequently compared
with the revised Cambridge Reference Sequence (rCRS)
with SeqScape software (Applied Biosystems).
Microscopy and quantification of histochemical
and immunohistochemical findings
To characterize respiratory-deficient muscle fibres,
respiratory-deficient, COX-positive and intermediate fibres
were captured using Zeiss Axioimager 2 with Axiovision
4.8 software (Zeiss, Cambridge, UK) at a magnification of
¥20. The density of respiratory-deficient fibres as a per-
centage of total muscle fibres was determined per case by
I.Z., who was blinded to case details and mutational analy-
sis. In order to determine the profile of mitochondrial res-
piratory chain complex subunits in paraspinal muscle
fibres, fibres with intact COX activity and respiratory-
deficient fibres were located using serial sections subjected
to COX/SDH histochemistry. Furthermore, respiratory-
deficient fibres were located according to heteroplasmy
level of mtDNA deletions (<60% or >60%) and mtDNA
depletion using serial sections; we were able to determine
mitochondrial respiratory chain subunit profiles, hetero-
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plasmy levels of mtDNA deletions and mtDNA copy
number within the same muscle fibres as serial cryostat
sections were cut onto both glass and membrane slides.
Fibres without either high heteroplasmy level of mtDNA
deletions or mtDNA depletion were identified as unex-
plained fibres in images of serial sections. Immunoreactiv-
ity in individual fibres was determined using densitometry
on greyscale images captured at identical settings. To
negate any interindividual variability, the mean densitom-
etry of 10 random COX-positive muscle fibres was deter-
mined in each case to use as a reference to establish a ratio
for each serial COX-deficient fibre.
Statistical analysis
All graphs and statistical comparisons were performed
using Graph Pad Prism 4 (GraphPad, San Diego, CA, USA).
Parametric test (t-test) was used to compare two groups.
When more than two groups were compared anova was
used. P-values of <0.05 were considered statistically
significant.
Results
The density of respiratory-deficient fibres in
paraspinal muscle and correlation with age
Respiratory-deficient muscle fibres were detected in all but
the two youngest cases (Figure 1). In the remaining 17
cases, the density of respiratory-deficient fibres varied from
0.71% to 10.28% with a mean of 3.96% (with the total
number of fibres analysed per case ranging from 635 to
1123) (Figure 1). Cases over 60 years of age harboured
Figure 1. The density of respiratory-deficient fibres in paraspinal muscle. (A) There were numerous respiratory-deficient fibres (lacking
complex IV activity and with intact complex II activity stained blue, arrowheads) apparent in paraspinal muscles following sequential
COX/SDH (mitochondrial respiratory chain complex IV/complex II) histochemistry. In addition, we observed respiratory-deficient and
complex II (SDH) hyper-reactive fibres indicative of subsarcolemmal mitochondrial accumulation (asterisks) and paraspinal muscle fibres
contained central cores, as previously noted (arrows and see Figure S1) [10]. Scale bar: 200 mm. (B–C) On average, 3.96% of muscle fibres
in paraspinals were respiratory-deficient (B). The mean density of respiratory-deficient fibres in cases over 60 years of age was 5.22%
compared with 2.56% in less than 60 years of age. There was a statistically significant (P = 0.04, r2 = 0.23) positive correlation between the
density of respiratory-deficient fibres and age (C).
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respiratory-deficient fibres at a mean density of 5.22%
compared with 2.56% in <60-year-olds. Furthermore,
there was a significant correlation between the density of
respiratory-deficient fibres in paraspinal muscles and age.
We did not observe a significant difference in the density of
respiratory-deficient fibres between peri-operative and
autopsy samples nor between muscle samples from cervi-
cal and lumbar regions (Figure S1). Histopathological find-
ings in paraspinal muscles included predominance of type
I fibres, atrophy of type II fibres and central cores, as previ-
ously reported [10], as well as type IIc fibres (Figure S2).
High heteroplasmy level of clonally expanded
mtDNA deletions within respiratory-deficient
paraspinal muscle fibres
Two populations of respiratory-deficient fibres were
apparent when levels of somatic mtDNA deletions were
determined in individual laser captured muscle fibres by
real-time PCR (Figure 2). Approximately 37% of all
respiratory-deficient fibres in paraspinal muscles con-
tained high levels (>60% mutation load) of mtDNA dele-
tion. In contrast, none of the muscle fibres with intact
Figure 2. Level of mitochondrial DNA (mtDNA) deletion in individual paraspinal muscle fibres. (A) Respiratory-deficient fibres (arrowhead)
were detected using sequential COX/SDH (mitochondrial respiratory chain complex IV/complex II) histochemistry on cryosectioned muscles
on membrane slides (Ai–Aii). Individual muscle fibres were laser captured into Eppendorf tubes (Aii insert) from serial sections subjected to
SDH histochemistry for molecular characterization. Scale bar: 200 mm. (B–C) Real-time polymerase chain reaction on DNA extracted from
individual respiratory-deficient (blue, COX-deficient or COX-) fibres and fibres with intact COX activity (brown, COX-positive) showed
significantly (P < 0.0001) higher heteroplasmy level of mtDNA deletions in COX- compared with COX+ fibres (B). Interestingly,
ascertainment of mtDNA heteroplasmy levels appeared to identify two populations of COX-deficient fibres. Approximately 37% of
COX-deficient fibres harboured >60% heteroplasmy levels of mtDNA deletions. When respiratory deficiency was analysed per case, there
were cases where approximately 80% of all respiratory-deficient fibres harboured high heteroplasmy levels (>60%) as well as cases where
mtDNA deletions did not explain the biochemical defect (C). COX-: respiratory-deficient or COX-negative; COX+: with intact complex IV
activity or COX-positive.
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COX activity contained high level of mtDNA deletion.
The percentage of respiratory-deficient fibres harbouring
high heteroplasmy levels of mtDNA deletions (>60%)
varied between cases, ranging from zero to 81.25%
when respiratory-deficient fibres were analysed per case
(Figure 2C). Histopathological features did not distinguish
cases where mtDNA deletion led respiratory deficiency
was predominant from cases where high heteroplasmy
levels of mtDNA deletions were sparse.
As next step, we used long-range PCR and breakpoint
sequencing to characterize mtDNA deletions observed
within paraspinal muscle fibres (Figure 3). The high
heteroplasmy level of mtDNA deletion in individual
respiratory-deficient fibres appeared to be due to expan-
sion of one clone of an mtDNA deletion or clonal expan-
sion, as single mtDNA deletions were detected in several
respiratory-deficient fibres. MtDNA deletions were also
detected when fibres with intact COX activity, where the
Figure 3. Confirmation of mitochondrial DNA (mtDNA) deletions and identification of breakpoints. (A–B) When DNA extracted from
individual respiratory-deficient paraspinal muscle fibres was subjected to long-range polymerase chain reaction (PCR), multiple mtDNA
deletions were detected. However, more than one or two mtDNA deletions within an individual fibre was rarely identified, suggestive of
clonally expanded mtDNA deletions (A). When DNA was extracted from 10 pooled fibres with intact mitochondrial respiratory chain
complex IV or cytochrome c oxidase (COX) activity, multiple mtDNA deletions were also detected (B); however, real-time data shown in
Figure 2 did not indicate expansion of mtDNA deletions to high heteroplasmy levels in such fibres. COX-deficient: fibres lacking complex IV
and with intact complex II activity. COX-positive: fibres with complex IV activity. + indicates full-length amplified product from wild-type
DNA. Lanes 1–8 (A) show amplified products of DNA extracted from individual fibres from different cases and lanes 1–6 (B) show 10 pooled
fibres, from different cases. (C) Sequencing of individual mtDNA deletions extracted following long-range PCR confirmed the mtDNA
deletions and identified breakpoints. MtDNA deletions were flanked by either a perfect (Ci) or an imperfect (Cii) repeat sequence as previously
reported in ageing [23].
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level of mtDNA deletion was lower than the threshold
(<60%), were pooled. Sequencing of gel-extracted DNA
following long-range PCR identified and characterized
the breakpoints of mtDNA deletions within respiratory-
deficient fibres (Figure 3C and Table S2).
Depletion of mtDNA in a proportion of
respiratory-deficient paraspinal muscle fibres
Besides clonally expanded mtDNA deletions, mtDNA
depletion is a well-recognized cause of respiratory defi-
ciency in skeletal muscle. Overall, respiratory-deficient
fibres contained significantly more mtDNA copies (wild-
type and deleted molecules) than fibres with intact COX
activity (Figure 4), as previously reported in limb skeletal
muscle and extraocular muscles (EOM) [19]. The wild-
type copy number, however, was significantly lower in
respiratory-deficient fibres with high heteroplasmy levels
compared with fibres with intact COX activity. Based on
the lower limit of 95% confidence interval of the total
copy number ratio in fibres with intact COX activity as the
threshold, 13.5% of all respiratory-deficient fibres demon-
strated mtDNA depletion in the absence of high levels of
mtDNA deletion.
Profile of immunohistochemically detected
respiratory chain complex subunits within
respiratory-deficient fibres in paraspinal muscle
Next we investigated whether the respiratory-deficient
fibres without high levels of mtDNA deletion or mtDNA
depletion (unexplained) differed at the level of mitochon-
drial respiratory chain complex subunits from fibres
where the respiratory deficiency was explained above. Fol-
lowing identification of fibres harbouring high hetero-
plasmy level of mtDNA deletions or mtDNA depletion,
immunoreactivity of complex I-20kDa, complex II-70kDa
and subunit-I of complex IV (COX-I) within individual
fibres in serial sections was assessed by densitometry
(Figure 5). Overall, complex I-20kDa and COX-I subunits
were significantly decreased within respiratory-deficient
fibres compared with fibres with intact COX activity. There
were respiratory-deficient fibres intensely stained with
complex II-70kDa consistent with COX-deficient fibres
that were hyper-reactive for SDH. The patterns of complex
I and complex IV subunits in the unexplained population
of respiratory-deficient fibres were similar to the popula-
tion explained by mtDNA deletions or mtDNA depletion.
Discussion
In this study we have established clonally expanded
mtDNA deletions and mtDNA depletion as causes of res-
piratory deficiency in paraspinal muscles from patients
undergoing surgery for degenerative spinal disease and
post mortem cases without a history of spinal disease. In
addition, we identified the density of respiratory-deficient
fibres in paraspinal muscles to be greater than previously
reported with ageing in limb skeletal muscle (<1.7%)
[13–15]. The significant correlation between respiratory
deficiency and age as well as clonally expanded mtDNA
deletions, which are well recognized in ageing limb
skeletal muscle [11,23], indicated that the respiratory
deficiency within paraspinal muscles is an age-related
phenomenon.
In contrast to limb skeletal muscles, the basis of
respiratory-deficient fibres within paraspinal muscles in
elderly subjects and cases with neuromuscular disorders
was not investigated [1,9,10,13–15,24]. There are funda-
mental differences between limb skeletal and paraspinal
muscles. With respect to embryonic origin and develop-
ment, the myogenic precursor cells that give rise to
paraspinal muscles are derived from the dorsal-medial
portion of dermomyotome whereas cells in ventral-lateral
portion migrate and form the limb muscles [25]. Paraspi-
nal muscle differentiation during initial stages of
development gives rise to mononucleated cells whereas
multinucleated cells are the product of differentiation in
limb skeletal muscles [26]. There is a predominance of
type I fibres in paraspinal muscles in contrast to limb skel-
etal muscles [10,27]. From a functional perspective,
paraspinal muscles are isometric compared with phasic or
dynamic movements of limb skeletal muscle [27]. The
above features may make paraspinal muscles more sus-
ceptible to age-related mtDNA deletions than limb skeletal
muscles.
The mtDNA deletions found in the present study are no
doubt occurring as somatic mutation as the cases did not
show a family history or clinical phenotype suggestive
of primary mitochondrial disease. Clonally expanded
mtDNA deletions, which may occur through random
genetic drift, are recognized within limb skeletal muscle
and the central nervous system in elderly subjects [14].
Although the mechanism of mtDNA deletion formation is
not fully elucidated, they are thought to form following
double-strand breaks mediated by DNA repair processes
[28]. Once mtDNA deletions are formed, the level of
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Figure 4. Total and wild-type mtDNA copies in individual paraspinal muscle fibres. (A) Ratio of total mitochondrial DNA (mtDNA) copies in
respiratory-deficient paraspinal muscle fibres [wild-type and deleted based on MTND1 values in real-time polymerase chain reaction (PCR)],
corrected for case to case variability by using the mean copy number of 10 fibres with intact mitochondrial respiratory chain complex IV or
cytochrome c oxidase (COX) activity (COX-positive) in each case, indicated a significantly greater total mtDNA copy number compared with
COX-positive fibres (A). When the lower limit of 95% confidence interval of total copy number ratios in COX-positive fibres were used to
identify fibres with mtDNA depletion (A, below the dotted line), we detected a number of respiratory-deficient fibres (13.5% of all
respiratory-deficient fibres) where total mtDNA copies were depleted in the absence of high level of mtDNA deletion. (B) Ratio of wild-type
mtDNA copies in respiratory-deficient paraspinal muscle fibres (based on MTND4 values in real-time PCR), corrected for variability in
wild-type mtDNA copies within fibres with intact COX activity (COX-positive), indicated a significantly decrease in wild-type mtDNA copies in
respiratory-deficient fibres with high heteroplasmy levels compared with COX-positive fibres (B). The increase in total mtDNA copies and
decrease in wild-type mtDNA copies in respiratory-deficient fibres were consistent with pathogenecity of high levels of mtDNA deletion,
previously reported [12,19]. When the lower limit of 95% confidence interval of wild type copy number ratios in COX-positive fibres were
used to identify fibres with mtDNA depletion (B, below the dotted line), a number of respiratory-deficient fibres (11.4% of all
respiratory-deficient fibres) with depletion of wild type mtDNA copies and without high level of mtDNA deletion was detected.
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Figure 5. The profile of immunohistochemically detected mitochondrial respiratory chain complex subunits in paraspinal muscle.
(A–D) The status of mitochondrial respiratory chain complex subunits was determined in relation to biochemical activity of paraspinal
muscle fibres by subjecting serial cryostat sections to histochemistry (A) and immunohistochemistry (B–D). A proportion of respiratory-
deficient fibres lacked complex I-20kDa (B, arrowheads) and subunit-I of complex IV or COX-I (c, arrowheads). In contrast, there were
respiratory-deficient fibres where COX-I and complex I-20kDa were detectable by immunohistochemistry (B–C, asterisk). Some fibres lacked
complex I-20kDa while retaining COX-I (B–C, arrows). In keeping with intact complex II activity, complex II-70kDa was detected within
respiratory-deficient fibres (D). Intense staining of some of the respiratory-deficient fibres within complex II-70kDa indicates mitochondrial
proliferation (D). Scale bar: 125 mm. (E) When immunoreactivity was analysed by densitometry, respiratory-deficient fibres demonstrated a
significant decrease in complex I-20kDa and COX-I compared with fibres with intact complex IV activity (brown). Interestingly, the status of
subunits within respiratory-deficient fibres where clonally expanded mitochondrial DNA (mtDNA) deletions at >60% heteroplasmy level or
mtDNA depletion did not explain the biochemical detect (unexplained) was similar to fibres where the biochemical detect was due to mtDNA
deletions or mtDNA depletion (E–F). COX/SDH, mitochondrial respiratory chain complex IV/complex II.
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mtDNA deletion needs to exceed a critical mutation
threshold before a biochemical defect results. The process
by which a single species of mtDNA deletion expands to
high heteroplasmy level is termed clonal expansion
[11,29,30]. Evidence from in vivo models of primary mito-
chondrial disorders suggests that factors such as replica-
tive advantage of deleted mtDNA molecules and metabolic
rate may influence the rate of clonal expansion in single
cells [30]. The fact that long-range PCR showed mtDNA
deletions within fibres with intact complex IV activity,
although not expanded to high levels, highlights the
potential of the paraspinal muscle to harbour mtDNA
deletions. The cases with clonally expanded mtDNA dele-
tions in their fourth or fifth decade of life at biopsy indi-
cated an early mutational event in paraspinal muscles
before clonal expansion occurred, as proposed by Elson
et al. [29]. The intrinsic properties of and functional
demand on paraspinal muscles may then drive clonal
expansion of mtDNA deletions and cause respiratory
deficiency; mtDNA deletions were abundant within
respiratory-deficient fibres in EOM, which share some of
the intrinsic properties of paraspinals [12,19]. The
increase in total copy number and a decrease in wild-type
copies of mtDNA in respiratory-deficient fibres with
greater than 60% heteroplasmy level are consistent with
the pathogenicity of clonally expanded mtDNA deletions
in paraspinal muscles. Interestingly, quantitative loss of
mtDNA copy number only accounted for a small propor-
tion of respiratory chain deficiency. Depletion of mtDNA
and impaired transcription of mitochondrial genes are
well recognized in denervated and disused or immobilized
muscles [31,32]. The small proportion of respiratory-
deficient fibres with mtDNA depletion is consistent with
ongoing use of paraspinal muscles in subjects that under-
went spinal surgery.
Clonally expanded mtDNA deletions and mtDNA deple-
tion explained the observed biochemical defect in appro-
ximately half of respiratory-deficient fibres within
paraspinal muscles. Previous reports that investigated
age-related mitochondrial defects in limb skeletal muscle
did not attempt to explain the respiratory failure com-
prehensively; studies either explained up to 10% of
respiratory-deficient fibres using techniques that were not
sensitive enough and only screened for specific mtDNA
mutations (for example, the 4977-bp ‘common deletion’)
or did not characterize a large number of respiratory-
deficient fibres [13–15]. As a result, the extent to which
mtDNA deletions and depletion explain the age-related
respiratory deficiency in limb skeletal muscles is unclear.
Based on the level of mtDNA deletion in fibres with intact
COX activity, the threshold necessary for a biochemical
defect in paraspinal muscle fibres appeared to be less than
reported in limb skeletal muscle and EOM [12]. Future
studies of paraspinal muscles from primary mitochondrial
cases may shed light on the heteroplasmy threshold nec-
essary for a biochemical defect in paraspinal muscles [7].
The studies that included immunohistochemical profiling
of skeletal muscles, used immunohistochemistry to
support a pathogenic role for mtDNA mutations rather
than as a guide to the underlying molecular defect where
mtDNA mutations were not apparent. A study of cases
with suspected primary mitochondrial disorders involving
COX-deficiency by Rahman et al. identified intact subunits
in respiratory-deficient fibres as a potential indicator of
nuclear DNA defects whereas loss of subunits was consis-
tent with mtDNA mutations [16,17]. MtDNA point muta-
tions may also form the basis of the biochemical defect in
a subset of unexplained respiratory-deficient fibres, given
the fact the majority of these unexplained respiratory-
deficient fibres lacked both COX-I and complex I-20kDa.
Future studies exploring mtDNA for point mutations may
explain the biochemical defect at least in a small subset of
respiratory-deficient fibres, similar to the findings in EOM
[19]. Post-transcriptional modifications to mitochondrial
subunits may also exist in paraspinal muscles. With the
greater understanding of the nuclear DNA and mitochon-
drial cross-talk the opportunities to completely explain the
basis of respiration deficiency in paraspinal muscles is
likely to increase [33].
In summary, mitochondrial defects including
respiratory-deficient fibres harbouring high levels of
mtDNA deletion were more frequent in paraspinal
muscles than previously recognized in ageing limb skeletal
muscles. Clonally expanded mtDNA deletions and mtDNA
depletion may contribute towards the age-related postural
abnormalities and certain axial myopathies in which
mitochondrial respiratory chain abnormalities are
reported.
Acknowledgements
This study was supported by the Wellcome Trust (Interme-
diate Clinical Fellowship to D.M.), Newcastle Healthcare
Charity (to D.M.), The Wellcome Trust Centre for Mito-
chondrial Research and the Newcastle University Centre
for Brain Ageing and Vitality funded by Biotechnology and
MtDNA deletions in paraspinal muscles 387
© 2012 The Authors
Neuropathology and Applied Neurobiology © 2012 British Neuropathological Society
NAN 2013; 39: 377–389
Biological Sciences Research Council, Engineering and
Physical Sciences Research Council, Economic and Social
Research Council and Medical Research Council as part of
the cross-council Lifelong Health and Wellbeing Initiative
(G0700718). We are grateful to Dr Laurie Bindoff for
helpful discussion on mitochondrial abnormalities in
paraspinal muscles. We thank Dr Djordje Gveric from UK
Multiple Sclerosis and Parkinson’s Tissue Bank for provid-
ing post mortem tissue and Mr Christopher Gerber from
Department of Neurosurgery, Newcastle General Hospital
for providing the peri-operative samples.
References
1 Delisle MB, Laroche M, Dupont H, Rochaix P, Rumeau JL.
Morphological analyses of paraspinal muscles: compari-
son of progressive lumbar kyphosis (camptocormia) and
narrowing of lumbar canal by disc protrusions. Neuro-
muscul Disord 1993; 3: 579–82
2 Schabitz WR, Glatz K, Schuhan C, Sommer C, Berger C,
Schwaninger M, Hartmann M, Hilmar Goebel H, Meinck
HM. Severe forward flexion of the trunk in Parkinson’s
disease: focal myopathy of the paraspinal muscles mim-
icking camptocormia. Mov Disord 2003; 18: 408–14
3 Serratrice G. Axial myopathies: an elderly disorder. Acta
Myol 2007; 26: 11–13
4 Serratrice G, Pouget J, Pellissier JF. Bent spine syndrome.
J Neurol Neurosurg Psychiatry 1996; 60: 51–4
5 Yoshiyama Y, Takama J, Hattori T. The dropped head sign
in parkinsonism. J Neurol Sci 1999; 167: 22–5
6 Hund E, Heckl R, Goebel HH, Meinck HM. Inclusion body
myositis presenting with isolated erector spinae paresis.
Neurology 1995; 45: 993–4
7 Sakiyama Y, Okamoto Y, Higuchi I, Inamori Y, Sangat-
suda Y, Michizono K, Watanabe O, Hatakeyama H, Goto
Y, Arimura K, Takashima H. A new phenotype of mito-
chondrial disease characterized by familial late-onset
predominant axial myopathy and encephalopathy. Acta
Neuropathol (Berl) 2011; 121: 775–83
8 Wakata N, Konno S, Nomoto N, Sugimoto H, Nemoto H,
Kurihara T, Kishi M. Myasthenia gravis with concomitant
severe paraspinal muscle degeneration and mitochon-
drial DNA4977 deletion. Intern Med 2007; 46: 747–50
9 Ramsbacher J, Theallier-Janko A, Stoltenburg-Didinger
G, Brock M. Ultrastructural changes in paravertebral
muscles associated with degenerative spondylolisthesis.
Spine (Phila Pa 1976) 2001; 26: 2180–4; discussion 5
10 Wharton SB, Chan KK, Pickard JD, Anderson JR. Paraver-
tebral muscles in disease of the cervical spine. J Neurol
Neurosurg Psychiatry 1996; 61: 461–5
11 Larsson NG. Somatic mitochondrial DNA mutations in
mammalian aging.AnnuRevBiochem2010;79: 683–706
12 Greaves LC, Yu-Wai-Man P, Blakely EL, Krishnan KJ,
Beadle NE, Kerin J, Barron MJ, Griffiths PG, Dickinson AJ,
Turnbull DM, Taylor RW. Mitochondrial DNA defects and
selective extraocular muscle involvement in CPEO. Invest
Ophthalmol Vis Sci 2010; 51: 3340–6
13 Brierley EJ, Johnson MA, Lightowlers RN, James OF,
Turnbull DM. Role of mitochondrial DNA mutations in
human aging: implications for the central nervous
system and muscle. Ann Neurol 1998; 43: 217–23
14 Bua E, Johnson J, Herbst A, Delong B, McKenzie D,
Salamat S, Aiken JM. Mitochondrial DNA-deletion muta-
tions accumulate intracellularly to detrimental levels in
aged human skeletal muscle fibers. Am J Hum Genet
2006; 79: 469–80
15 Fayet G, Jansson M, Sternberg D, Moslemi AR, Blondy P,
Lombes A, Fardeau M, Oldfors A. Ageing muscle: clonal
expansions of mitochondrial DNA point mutations and
deletions cause focal impairment of mitochondrial func-
tion. Neuromuscul Disord 2002; 12: 484–93
16 Rahman S, Lake BD, Taanman JW, Hanna MG, Cooper
JM, Schapira AH, Leonard JV. Cytochrome oxidase
immunohistochemistry: clues for genetic mechanisms.
Brain 2000; 123: 591–600
17 De Paepe B, Smet J, Lammens M, Seneca S, Martin JJ, De
Bleecker J, De Meirleir L, Lissens W, Van Coster R. Immu-
nohistochemical analysis of the oxidative phosphoryla-
tion complexes in skeletal muscle from patients with
mitochondrial DNA encoded tRNA gene defects. J Clin
Pathol 2009; 62: 172–6
18 Johnson MA, Bindoff LA, Turnbull DM. Cytochrome c
oxidase activity in single muscle fibers: assay techniques
and diagnostic applications. Ann Neurol 1993; 33: 28–
35
19 Yu-Wai-Man P, Lai-Cheong J, Borthwick GM, He L,
Taylor GA, Greaves LC, Taylor RW, Griffiths PG, Turnbull
DM. Somatic mitochondrial DNA deletions accumulate to
high levels in aging human extraocular muscles. Invest
Ophthalmol Vis Sci 2010; 51: 3347–53
20 Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ,
Reynolds R, Howell O, Lassmann H, Turnbull DM,
Mahad DJ. Mitochondrial DNA deletions and neurode-
generation in multiple sclerosis. Ann Neurol 2011; 69:
481–92
21 He L, Chinnery PF, Durham SE, Blakely EL, Wardell TM,
Borthwick GM, Taylor RW, Turnbull DM. Detection and
quantification of mitochondrial DNA deletions in indi-
vidual cells by real-time PCR. Nucleic Acids Res 2002; 30:
e68
22 Krishnan KJ, Bender A, Taylor RW, Turnbull DM. A mul-
tiplex real-time PCR method to detect and quantify mito-
chondrial DNA deletions in individual cells. Anal Biochem
2007; 370: 127–9
23 Reeve AK, Krishnan KJ, Turnbull D. Mitochondrial DNA
mutations in disease, aging, and neurodegeneration. Ann
N Y Acad Sci 2008; 1147: 21–9
24 Brierley EJ, Johnson MA, James OF, Turnbull DM. Effects
of physical activity and age on mitochondrial function. Q
J Med 1996; 89: 251–8
388 G. R. Campbell et al.
© 2012 The Authors
Neuropathology and Applied Neurobiology © 2012 British Neuropathological Society
NAN 2013; 39: 377–389
25 Ordahl CP, Le Douarin NM. Two myogenic lineages
within the developing somite. Development 1992; 114:
339–53
26 Keynes RJ, Stern CD. Mechanisms of vertebrate segmen-
tation. Development 1988; 103: 413–29
27 Regev GJ, Kim CW, Thacker BE, Tomiya A, Garfin SR,
Ward SR, Lieber RL. Regional myosin heavy chain distri-
bution in selected paraspinal muscles. Spine (Phila Pa
1976) 2010; 35: 1265–70
28 Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Black-
wood JK, Taylor RW, Wanrooij S, Spelbrink JN, Lightowl-
ers RN, Turnbull DM. What causes mitochondrial DNA
deletions in human cells? Nat Genet 2008; 40: 275–9
29 Elson JL, Samuels DC, Turnbull DM, Chinnery PF.
Random intracellular drift explains the clonal expansion
of mitochondrial DNA mutations with age. Am J Hum
Genet 2001; 68: 802–6
30 Nicholas A, Kraytsberg Y, Guo X, Khrapko K. On the
timing and the extent of clonal expansion of mtDNA
deletions: evidence from single-molecule PCR. Exp Neurol
2009; 218: 316–19
31 Chen YW, Gregory CM, Scarborough MT, Shi R, Walter
GA, Vandenborne K. Transcriptional pathways associ-
ated with skeletal muscle disuse atrophy in humans.
Physiol Genomics 2007; 31: 510–20
32 Vielhaber S, Kunz D, Winkler K, Wiedemann FR, Kirches
E, Feistner H, Heinze HJ, Elger CE, Schubert W, Kunz WS.
Mitochondrial DNA abnormalities in skeletal muscle of
patients with sporadic amyotrophic lateral sclerosis.
Brain 2000; 123: 1339–48
33 McFarland R, Taylor RW, Turnbull DM. A neurological
perspective on mitochondrial disease. Lancet Neurol
2010; 9: 829–40
Supporting information
Additional Supporting Information may be found in the
online version of this article:
FigureS1.Histopathological features of paraspinal muscle.
(A–F) H&E stain (A) showed variable fibre diameter and
spaces presumably represent replacement adipose tissue
following fibre loss. COX/SDH histochemistry identified
respiratory-deficient fibres (B, arrowheads) as well as fibres
with intact COX activity (B, containing brown DAB
product). Central cores were apparent in many fibres, as
previously reported (B–C) [10]. A serial section (C), which
reacted for SDH histochemistry, showed intact complex II
activity (arrowheads) in respiratory-deficient fibres (com-
pared with the same fibre in B) as well as fibres where
COX/SDH histochemistry identified complex IV activity
(stained brown in B). Immunohistochemistry for slow (D)
and fast (E) myosin heavy chain identified a predominance
of type I muscle fibres and also atrophy of type II muscle
fibres (E, arrowheads). ATPase pH 4.3 reactivity confirmed
the predominance of type I fibres and identified type IIc
fibres in paraspinal muscles (F, arrowheads). DAB: 3,
3′-Diaminobenzidine. Scale bar: 200 mm.
Figure S2. Comparison of respiratory deficiency and high
levels of mtDNA deletion in individual fibres between
surgical and post mortem cases and cervical and lumbar
paraspinal muscles. (A–B) When the density of
respiratory-deficient fibres within paraspinal muscles in
peri-operative samples and from post mortem cases were
compared we did not identify a significant difference
between the two groups (A). The percentage of
respiratory-deficient fibres harbouring high heteroplasmy
level of mtDNA deletions was also not significantly differ-
ent between peri-operative samples and tissue derived
from post mortem cases, which is consistent previous
observations (B) [10]. Furthermore, we did not identify
a significant difference in the density of respiratory-
deficient fibres or the percentage of respiratory-deficient
fibres harbouring high heteroplasmy level of mtDNA
deletions between cervical and lumbar deep paraspinal
muscles (C–D).
Table S1. Details of primary antibodies.
Table S2. MtDNA deletion breakpoints identified in
respiratory-deficient paraspinal muscle fibres.
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